The activation of NLRP3 inflammasome induces the release of pro-inflammatory cytokines such as IL-1β and IL-18, which exacerbate liver inflammation and cell damage, thus promoting the progression of NAFLD (Kanno et al., 2022). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.